Abstract:Abnormal accumulation of tau proteins is one pathological hallmark of Alzheimer's disease (AD). Many tau protein post-translational modifications (PTMs) are associated with the development of AD, such as phosphorylation, acetylation, and methylation. Therefore, a complete picture of PTM landscape of tau is critical for understanding the molecular mechanisms of AD progression. Here, we offered a pilot study of combining two complementary analytical techniques, capillary zone electrophoresis (CZE)-tandem mass spectrometry (MS/MS) and reversed-phase liquid chromatography (RPLC)-MS/MS, for bottom-up proteomics of recombinant human tau-0N3R. We identified 53 phosphorylation sites of tau-0N3R in total, which is about 30% higher than that from RPLC-MS/MS alone. CZE-MS/MS provided more PTM sites (i.e., phosphorylation) and modified peptides of tau-0N3R than RPLC-MS/MS, and its predicted electrophoretic mobility helped improve the confidence of the identified modified peptides. We developed a highly efficient capillary isoelectric focusing (cIEF)-MS technique to offer a bird's-eye view of tau-0N3R proteoforms, with 11 putative tau-0N3R proteoforms carrying up to nine phosphorylation sites and lower pI values from more phosphorylated proteoforms detected. Interestingly, under a native-like cIEF-MS condition, we observed three putative tau-0N3R dimers carrying phosphate groups. The findings demonstrate that CE-MS is a valuable analytical technique for the characterization of tau PTMs, proteoforms, and even oligomerization.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is to conduct a detailed analysis of post - translational modifications (PTMs) and proteoforms of tau protein by combining capillary electrophoresis - mass spectrometry (CE - MS) and reversed - phase liquid chromatography - mass spectrometry (RPLC - MS), with particular attention to the phosphorylation modification of tau protein. Specifically, the research objectives are: 1. **Comprehensive analysis of PTMs of tau protein**: Abnormal accumulation of tau protein is a pathological hallmark of Alzheimer's disease (AD), and various post - translational modifications of tau protein, such as phosphorylation, acetylation and methylation, are closely related to the development of AD. Therefore, a complete mapping of PTMs of tau protein is crucial for understanding the molecular mechanisms of AD. 2. **Evaluating the advantages of CE - MS in tau protein analysis**: By comparing the performance of CE - MS/MS and RPLC - MS/MS in identifying PTMs and modified peptides of tau protein, evaluate the advantages of CE - MS in analyzing highly modified samples. Studies have shown that CE - MS/MS can identify more phosphorylation sites and modified peptides, and its predicted electrophoretic mobility helps to improve the confidence of modified peptide identification. 3. **Exploring the complete forms (proteoforms) of tau protein**: Using capillary isoelectric focusing - mass spectrometry (cIEF - MS), observe different forms of tau protein as a whole, including tau protein forms carrying different combinations of PTMs. The study found that cIEF - MS can detect 11 potential tau - 0N3R protein forms, some of which carry as many as 9 phosphorylation sites, and as the degree of phosphorylation increases, the isoelectric point (pI) values of these protein forms decrease and the migration time increases. 4. **Observing the oligomerization phenomenon of tau protein**: In cIEF - MS analysis under near - physiological conditions, the researchers also observed three possible tau - 0N3R dimers, which carry phosphate groups. This finding further demonstrates the potential of CE - MS in analyzing PTMs, proteoforms and oligomerization phenomena of tau protein. In summary, this paper aims to conduct a comprehensive and in - depth analysis of PTMs and proteoforms of tau protein through advanced mass spectrometry techniques, especially CE - MS, in order to provide new insights into understanding the molecular mechanisms of AD.

A pilot study for deciphering post-translational modifications and proteoforms of tau protein by capillary electrophoresis-mass spectrometry